Wells Fargo & Company A Ikido Pharma Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 28 shares of AIKI stock, worth $106. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 28
-0.0%
Holding current value
$106
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AIKI
# of Institutions
18Shares Held
461KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA193KShares$734,8890.0% of portfolio
-
Black Rock Inc. New York, NY72.5KShares$275,5720.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny42.9KShares$163,1180.0% of portfolio
-
Geode Capital Management, LLC Boston, MA39.2KShares$149,0700.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX37.4KShares$142,0280.0% of portfolio
About AIkido Pharma Inc.
- Ticker AIKI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,485,100
- Market Cap $20.8M
- Description
- AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...